VIRO-FLOW is a recently funded Horizon 2020 project that aims to integrate the advantages of continuous flow chemical synthesis with in vitro microfluidic bioassay technologies for the fast and efficient discovery of inhibitors of hepatitis B virus (HBV).
The research programme is composed of three closely related projects in the fields of medicinal chemistry, molecular biology/ protein biochemistry and computational chemistry, and will provide exceptional training in drug discovery and enabling technologies for three Early-Stage Researchers (ESRs).
The ESRs will be supported by a network of experts at AiCuris, an infectious disease-focused biotech company, and the Institute of Chemical Research of Catalonia (ICIQ), a research institute focused on sustainable chemistry in the fields of catalysis and flow chemistry. The ESR training will include international, interdisciplinary and inter-sectorial mobility, and will integrate academic and industrial contributions.
More information and applications here